Internationale Studie unter der Leitung von PD Dr. Tatiana Brémová-Ertl der #InselGruppe und der Universität Bern bringt Hoffnung für Patientinnen und Patienten, die an der seltenen neurodegenerativen Krankheit Niemann-Pick Typ C leiden. Mehr: inselgruppe.ch/de/aktuell/det…

🎉 Celebrating 10 years of ESOC🎉It's #ThrowbackThursday . Join us as we embark on a nostalgic journey through the second ESOC, in 2016 in Barcelona. ow.ly/efCb50QXqt6
#voiceofstroke #stroke #TBT #ESOC2024 #stroke science #stroke twitter Ellis van Etten Aristeidis Katsanos

In a Review, David Seiffge and colleagues provide an update on secondary stroke prevention in people with atrial fibrillation: thelancet.com/journals/laneu…
@strokebern
@ash_shoamanesh
@fishingNeurons
Valeria Castro
@UCLstrokeRes
@raberLorenz

Secondary stroke prevention in people with AF - published ⁦The Lancet Neurology⁩! fantastic team work valeria caso⁩ ⁦Lorenz Räber, MD PhD⁩ ⁦Urs Martin Fischer⁩ ⁦UCL Stroke Research⁩ ⁦Ashkan Shoamanesh⁩ ⁦European Stroke Org⁩ ⁦Stroke Research Center Bern⁩ authors.elsevier.com/a/1inIG5FFzL0D…

🎆Urs Fischer and the The ELAN Trial team won the Maupertuis Research Prize 2024, awarded by the Swiss Brain League, for their results on the effective and safe use of early #anticoagulation for #stroke . 👉hirnliga.ch/de/forschungsp… Urs Martin Fischer Stroke Research Center Bern Universität Bern Insel Gruppe

Great start of the #BrainAwarenessWeek in Bern! The Swiss Brain League has awarded the Maupertuis Research Prize to the The ELAN Trial 💊 Sincere congratulations to the entire research team and all the recruiting sights 🏆 Urs Martin Fischer
Stroke Research Center Bern IBRO - International Brain Research Organization
Dana Foundation🧠 #BAW2024

Tolle News!!! Forschungsgruppe von Prof. Urs Fischer & Forschungsteam der #ELAN -Studie gewinnen Maupertuis-Forschungspreis 2024 der Schweizerischen Hirnliga! Mehr dazu: hirnliga.ch/fileadmin/user…
Urs Martin Fischer The ELAN Trial Stroke Research Center Bern Universität Bern Faculty of Medicine, University of Bern

Deeply honoured to receive this amazing award on behalf of the entire ELAN trial team!
Many thanks to all people who have contributed to this great endeavor!
Extremely grateful to the Swiss Brain League.

Thanks for highlighting the importance ti get additional data on IVT in patients on DOACS. We will just DO-IT Trial & Registry !@janpurrucker Thomas Meinel Teddy Wu Espen Saxhaug Kristoffersen Ashkan Shoamanesh Aristeidis Katsanos Luciana Catanese, MD Guri Hagberg Stroke Research Center Bern European Stroke Master Urs Martin Fischer

Swiss trial of decompressive craniectomy versus best medical treatment of spontaneous supratentorial intracerebral haemorrhage (SWITCH): an international, multicentre, randomised-controlled, two-arm, assessor-blinded trial journals.sagepub.com/doi/10.1177/23…

AshuJadhav Congratulations on this protocol paper! Looking forward to seeing the results at #ESOC2024 !

The 2024 European European Stroke Master is up and running 👏👏🧠🧠♥️♥️
37 participants from 27 countries - wow !!
Should it maybe be called Global Stroke Master?
Simon Jung

Decompressive craniectomy for people with severe deep intracranial haemorrhage? The protocol of the SWITCH trial has just been published in the ESJ. Results will be presented at ESOC 2024 in Basel in May! Stay tuned! ⁦⁦⁦⁦European Stroke Org⁩ journals.sagepub.com/doi/10.1177/23…

New data from The ELAN Trial presented by Stroke Research Center Bern Urs Martin Fischer and Martina Göldlin suggest that benefit of early start of DOAC after stroke is equal for all stroke sizes, probably even biggest in large sized strokes. Investigators did a great job estimimating stroke size 👏👏

Fresh analysis from ANNEXa-I by PHRI.ca Population Health Research Institute 🇨🇦 Ashkan Shoamanesh: hematoma growth rate (volume/time from onset) predicts subsequent hematoma expansion and reduction of HE with andexanet is substantial across different metrics Stroke AHA/ASA

Time matteres for intravenous thrombolysis prior thrombectomy - results of our meta-analysis just published in JAMA.
Many thanks to Johannes Kaesmacher and the whole IRIS Team for the great collaboration.Johannes Kaesmacher Fabiano Manon Kappelhof Kilian Treurniet

Time matteres for intravenous thrombolysis prior thrombectomy - results of our meta-analysis just published in JAMA.
Many thanks to Johannes Kaesmacher and the whole IRIS Team for the great collaboration.Johannes Kaesmacher Fabiano Manon Kappelhof Kilian Treurniet

Time matteres for IVT prior to thrombectomy! Great presentation of Johannes Kaesmacher from Stroke Research Center Bern at ISC and simultaneous publication in JAMA #alleyesoniris Fabiano Manon Kappelhof Kilian Treurniet Urs Martin Fischer

jamanetwork.com/journals/jama/…

Heureux d'accueillir le Prof. Urs Fischer Urs Martin Fischer de Berne pour notre Réunion du Service de neurologie le 6 février pour ce qui promet d'être une conférence fascinante sur l'éternelle question: quand débuter l'anticoagulation après un AVC cardioembolique?CHUM

Looking forward to welcoming Urs Martin Fischer this week Service de neurologie du CHUM for what should be a fascinating talk on optimal timing of anticoagulation start after AF-related stroke
CHUM